Skip to Main Content

Press Releases

Sept. 15, 2022

Nelson Mullins Represents Maxim Group LLC in $9.6 Million IPO for Nexalin Technology, Inc.

WASHINGTON, D.C. – Nelson Mullins represented Maxim Group LLC (“Maxim”) in the initial public offering (“IPO”) for Nexalin Technology, Inc. (“Nexalin”). The IPO has a total value of $9.6 million as Nexalin trades on the Nasdaq Capital Market tier of the Nasdaq Stock Market ("Nasdaq") under the symbols "NXL" and “NXLIW”, respectively.

The Nelson Mullins team was led by partner Andy Tucker and associate Kacey Heekin-Luchin. They were supported by partners Christopher Hanson, Wells Hall, and Nichole Hayden.

Maxim is a leading full-service investment bank, securities and wealth management firm headquartered in mid-town Manhattan. It provides a comprehensive array of financial services including investment banking, global institutional sales, equity research, fixed income, and derivative sales and trading, merchant capital, private wealth management, and prime brokerage services to a diverse range of corporate clients, institutional investors, and high-net-worth individuals.

Nexalin designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. All of Nexalin’s products are non-invasive and undetectable and, critically, can provide relief to those afflicted with mental health issues without adverse side effects. Nexalin previously developed an easy-to-administer medical device that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy.

Tucker is a corporate and securities advisor to growing companies, particularly in the technology and government contracting sectors. He assists his clients with a broad variety of transactional support, including venture capital and private equity transactions, joint ventures, mergers and acquisitions, and public and private securities offerings.

Heekin-Luchin focuses her practice on mergers and acquisitions, securities law, and health law.  She represents and advises buy-side and sell-side clients, investment banks, and issuers in connection with a broad range of general corporate transactional matters and public and private offerings, including initial public offerings, follow-on offerings, and private placements.

Read the press release.

Established in 1897, Nelson Mullins is an Am Law 100 firm of more than 930 attorneys and government relations professionals with 30 offices in 14 states and Washington, D.C. For more information on the firm, go to www.nelsonmullins.com.